$5.37
-0.02[-0.37%]
Last update: 11:00AM Get Real Time Here
Lyra Therapeutics
(NASDAQ:LYRA)Lyra Therapeutics Stock (NASDAQ:LYRA), Earnings Estimates, EPS, and Revenue
Lyra Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 10
EPS Estimate
$-0.260
Quarterly Revenue Estimate
$420K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$1.6M
Analyze the earnings history of Lyra Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/10/2024 | AM | LYRA | Q1 | -$0.44 | -$0.26 | — | — | $410.00K | $420.00K | — | — | Get Alert |
| 03/21/2024 | PM | LYRA | Q4 | -$0.32 | -$0.31 | -$0.22 | 29.03% | $11.00K | $390.00K | $146.00K | -62.56% | Get Alert |
| 11/07/2023 | PM | LYRA | Q3 | -$0.40 | -$0.32 | -$0.27 | 15.62% | $359.00K | $370.00K | $544.00K | 47.03% | Get Alert |
| 08/08/2023 | PM | LYRA | Q2 | -$0.43 | -$0.42 | -$0.36 | 14.29% | $407.00K | $140.00K | $458.00K | 227.14% | Get Alert |
| 05/12/2023 | AM | LYRA | Q1 | -$0.92 | -$0.36 | -$0.44 | -22.22% | $468.00K | $160.00K | $410.00K | 156.25% | Get Alert |
| 03/29/2023 | PM | LYRA | Q4 | -$1.05 | -$0.41 | -$0.32 | 21.95% | $271.00K | $150.00K | $11.00K | -92.67% | Get Alert |
| 11/08/2022 | PM | LYRA | Q3 | -$0.85 | -$0.44 | -$0.40 | 9.09% | $14.00K | $140.00K | $359.00K | 156.43% | Get Alert |
| 08/09/2022 | AM | LYRA | Q2 | -$0.85 | -$0.37 | -$0.43 | -16.22% | $0.00 | $1.44M | $407.00K | -71.74% | Get Alert |
| 05/10/2022 | AM | LYRA | Q1 | -$0.60 | -$0.91 | -$0.54 | 40.66% | $0.00 | $1.25M | $5.37M | 329.36% | Get Alert |
| 03/09/2022 | AM | LYRA | Q4 | -$0.46 | -$0.97 | -$1.05 | -8.25% | $0.00 | — | $271.00K | — | Get Alert |
| 11/09/2021 | PM | LYRA | Q3 | -$0.49 | -$0.73 | -$0.85 | -16.44% | $0.00 | — | $14.00K | — | Get Alert |
| 08/09/2021 | PM | LYRA | Q2 | -$0.56 | -$0.59 | -$0.85 | -44.07% | $0.00 | — | $0.00 | — | Get Alert |
| 05/11/2021 | PM | LYRA | Q1 | -$18.70 | -$0.48 | -$0.60 | -25.00% | $0.00 | — | $0.00 | — | Get Alert |
| 03/09/2021 | PM | LYRA | Q4 | — | -$0.56 | -$0.46 | 17.86% | — | — | $0.00 | — | Get Alert |
| 11/10/2020 | PM | LYRA | Q3 | — | — | -$0.49 | — | — | — | $0.00 | — | Get Alert |
| 08/05/2020 | PM | LYRA | Q2 | — | -$0.38 | -$0.56 | -47.37% | — | — | $0.00 | — | Get Alert |
| 05/28/2020 | AM | LYRA | Q1 | — | — | -$18.70 | — | — | — | $0.00 | — | Get Alert |
FAQ
When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?
Lyra Therapeutics (LYRA) is scheduled to report earnings on May 10, 2024. The last reported earnings were for reported on March 21, 2024 for Q4.
What were the latest earnings per share (EPS) for Lyra Therapeutics (NASDAQ:LYRA)?
The Actual EPS was $-0.22, which beat the estimate of $-0.31.
What were Lyra Therapeutics’s (NASDAQ:LYRA) revenues?
The Actual Revenue was $146K, which missed the estimate of $390K.
Browse earnings estimates, EPS, and revenue on all stocks.